Page last updated: 2024-10-31

metyrapone and Leukemia, Radiation-Induced

metyrapone has been researched along with Leukemia, Radiation-Induced in 1 studies

Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.

Leukemia, Radiation-Induced: Leukemia produced by exposure to IONIZING RADIATION or NON-IONIZING RADIATION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Resnitzky, P1
Estrov, Z1
Haran-Ghera, N1

Other Studies

1 other study available for metyrapone and Leukemia, Radiation-Induced

ArticleYear
High incidence of acute myeloid leukemia in SJL/J mice after X-irradiation and corticosteroids.
    Leukemia research, 1985, Volume: 9, Issue:12

    Topics: Adrenal Cortex Hormones; Animals; Female; Leukemia, Myeloid, Acute; Leukemia, Radiation-Induced; Met

1985